Medical Forum / Diseases and Disorders / AIDS / December 2004
Seems one or two more didn't fit page two
|
|
Thread rating:  |
PaulKing - 13 Dec 2004 12:08 GMT Ulrich Werner, DVM, Veterinarian, Public Health Inspector, Sta. cruz De Tenerife, Spain Ulmer Friedrich, PhD, Professor of Mathematics and Statistics, Bergische University, Wuppertal, Germany Umile John J., Medical Virology Researcher, Union County College, New Jersey Valencia Larry, M.S. Pharmaceutical Science, writer, Wyoming, Rhode Island Vallati Gian Paolo, Film Director, Writer, Roma, Italy Van Beveren A., PhD, Biochemist/Physiologist, Director, Health Integration Center, Skillman, New Jersey Van Camp Jean, M.A., New Martinsville, West Virginia Van Dam Marcus, MD, Scarborough, UK Van der Merwe Steven, Journalist – Times Media Ltd, Johannesburg, South Africa Van Hoek Karen, PhD, Ann Arbor, Michigan Van Sligtenhorst M.H., MD, Amsterdam, Netherlands Vasquez-sandoval Ricardo, MD, M.Sc., Prof. of Immunology, Universidad de Concepcion, Chillan, Chile Vergini Raul, MD (Predappio, Italy) Vibbert, Terry S., DDS, Evansville, Indiana Vidal Ana, Medical Student, University PUC-SP, Sorocaba, Brazil Vidal Gonzalo, D.C., Hayward, California Vital Higinio, Engineer, Madrid, Spain Vlaardingerbroek Barend, PhD, Senior Lecturer, Dept of Mathematics and Science, University of Botswana Vohland Janie, Registered Nurse; First Aid/CPR Instructor, Salem, Oregon Volpe Giovanna, MA, Sydney, Australia Von Goldammer E., Professor of Biophysics and Cybernetics, FH-Dortmund, Dortmund, Germany Vrcek Valerije, M.Sc., Faculty of Pharmacy and Biochemistry, University of Zagreb, Croatia Wagener William, PhD, Associate Professor, Microbiology, Clinical Laboratory Science, West Liberty State College, West Virginia Wahl Allene R., PhD, C.N.C., Founder: International Resource Center for Chemically Induced Immune Disorders, Franklin Park, Illinois Walde-miskel Kinefe, M.A., Köln, Germany Walton Michele, Documentary Film Maker, St. Louis, Missouri Warner James H., LLD (Rohersville, Maryland) Wawszkiewicz Edward J., PhD (Chicago, Illinois) Wei Yeh Da, MD, Hsin-Chu City, Taiwan Weiss Barnett J., CSW, HEAL Board Member, Brooklyn, New York Wells Darrell G., PhD (Emeritus Professor, Plant Sciences, Brookings, South Dakota) Wells Johathan C., PhD (Fairfield, California) Wenner Adrian M., PhD (Dept. Biol. Sciences, Univ. Cal., Santa Barbara, California) Wentzel Louise, Complimentary Health Practitioner, Cape Town, South Africa Wetter Manfred, PhD (Copperbelt Univ., Kitwe, Zambia) Whittaker Mark, M.Phil University of Glasgow, Copenhagen, Denmark Wicker Kenneth D. MD, Physician, Internal Medicine, Jefferson City, Tennessee Wieland Theodor, PhD (Max Planck Institut, Heidelberg, Germany) Wilcox Jon, Dr., Physician, MBChB, DipObst, FRNZCGP, Auckland, New Zealand. Also served on government committees dealing with pharmaceuticals and classification of pharmaceuticals. Wilder David J., MD, Physician, Augsburg, Bavaria, Germany Wilder Karl, Nutritionist, New York Willmott Annette, Registered Nurse, certified midwife, Sydney, Australia Wilson Ashley, Engineer, Milano, Italy Winicur Zev, PhD, Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder Winterrowd Dan, M.A., Pilot Hill, California Wofford Wade, Addictions Counselor, Birmingham, Alabama Wójcik Jacek, PhD, Chemist, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warszawa, Poland Wolfe Derek A., DBM (North Devon, UK) Wolke Gerald T., Pharmacist, Vallejo, California Wolman Lee Marc G., Civil Engineer, Belmont, Massachusetts, B.A., B.E., Johns Hopkins University, M.S., Harvard University Work L.B., MD (Monterey, California) Worthington James L., Registered Nurse, Director of Nursing, Central Florida Rehabilitation Complex, Mount Dora, Florida Wu Hung-His, PhD (Dept. Math. Univ. Cal., Berkeley, California) Wu James, MD (Foster City, California) Xu Chun, MD, PhD, McGill University, Montreal, Canada Yañez, Jose Antonio, Naturopathic Doctor, Monterrey, Mexico Yarbrough David W., MFA, Silver Spring, Maryland Yeung Wai, MD (Orinda, California) Young Ian, Author, Toronto, Canada Zajac Vladimir, PhD, Oncovirologist, Geneticist, Cancer Research Institute, Czech Republic Zanella Doretta, Veterinarian, Torino, Italy Zuhrbrigghen Mark, PhD, Orthomolecular Nutritionist, Cape Town, South Africa Zyskowski Stanley J., PhD (Farmington Hills, Michigan) More Scientists, Medical Professionals and Academics Who Disagree with the Hiv/Aids Establishment: Almendro Manuel, PhD in Psychology, (Spain) Arias Montse, journalist, Director of the Spanish version of the journal The Ecologist and of the newsletter Vida Sana, press reporter of Biocultura, Spain. Aubry Claude, Physician, Florida Berken, Arthur, MD “Is the human immunodeficiency virus really the initiator of human immunodeficiency?” (letter) New York State Journal of Medicine (February 1988), pp. 85-86. Brighthope Ian, MBBS, DipAgrSc, MATA, FACNEM, Australia, President of the Complementary Healthcare Council of Australia and the Australasian College of Nutritional and Environmental Medicine; author, The AIDS Fighters Campos Dr. Nicolas, Los Angeles, naturopathic physician, chiropractor, degree in Molecular Biology from UC Berkeley Chamorro Dr. Jimmy, Honorable Senator, Colombian Republic (AIDS without HIV: A new path for researching in the next century) Costa Dr. Enric, MD, Valencia, Spain, author, SIDA: Juicio a un virus inocente (“AIDS: An innocent virus on trial”) De Avellaneda Elieth Gomez, N.D., Bucaramanga, Colombia De Castro Costa Mauricio, MD, PhD, Professor of Neurology and Physiology, University Hospital and Department of Physiology, Universidad Federal do Ceara, Ceara, Brazil. Deshmukh Dr. N.T., Nagpur, India De Villegas Nhora Merino, MD, Head of the Laboratory of Pathology and Clinical Laboratory of the Fundacian Santa Fe de Bogota Edwards, Nigel, MA, Journalist, England Feast James, PhD, New York University, former Assistant Editor of the Journal of the History of Philosophy Gomez Elliet, ND, Colombia Incao Philip, MD, Steiner Holistic Medical, Denver, Colorado Ippolito Prof. Ferdinando, co-author, AIDS – New Frontier Mavligit Giora. Concluded that their results “strongly support the hypothesis that allogenic sperm is an etiologic factor in the pathogenesis of acquired immune dysregulation among homosexual males” who practice anal sex. McKenna Joan, Dr., Research Physiologist, Institute for Thermobaric Studies, Berkeley, California. Mendoza Dr. Antonio, MD, president, Colombian Association for the Scientific Reappraising of the Etiology of AIDS (TOXISIDA) Moise Francelot, MD, Haitian physician living in South Florida Ojeih Dr. Paul Olisa Adaka, Medical Director, Iris Medical Foundation, Lagos, Nigeria, author, Man and Diseases, AIDS: The Untold Truth and Cure, and AIDS: The Plague That Never Existed. Palacín Montserrat, MD, President of Spanish Kousmine Association, Expert in RPG, Barcelona, Spain Prada Dr. Mario Camacho, Governor of the State of Santander, Columbia Quagliarello - proposed sperm exposure as a possible cause of AIDS in 1982 (rectally-deposited sperm has been found to be immunosuppressive in rabbits) Rey Claudia J. G., RN, Bucaramanga, Colombia Ródenas Pedro, MD, founder of Integral, Natura Medicatrix magazines and the Center for Integrative Medicine of Barcelona Sanchez Adda, MD and homeopathic doctor Soler Wilmer, MD, Spain/ Colombia Suarez Elsa, PhD, Bucaramanga, Colombia Verzini Dr. Eduardo, MD, Argentina Wells Martin, Editor, Noseweek, Cape Town, South Africa Zaninovic Vladimir, MD, Emeritus Professor of Neurology, Universidad del Valle, Santiago de Cali, Colombia
.....and the latest 2,000 (approx) have not been catalogued yet.
Death - 14 Dec 2004 02:15 GMT "PaulKing" <aimulti@aimultimedia.com> wrote in message
> Ulrich Werner, DVM, Veterinarian, Public Health Inspector, Sta. cruz De > Tenerife, Spain Answering the AIDS Denialists: Is AIDS Real?
AIDS TREATMENT NEWS Issue #356, December 1, 2000 Bruce Mirken
---------------------------------------------------------------------------- ---- [Note: AIDS TREATMENT NEWS has published a series of articles looking in depth at some of the bizarre ideas about AIDS, theories which are being used to persuade people to change or completely stop their medical treatment, or to ignore precautions for preventing HIV infection. One of the most bizarre is that the epidemic does not exist but is just a new name for a collection of old diseases. AIDS writer Bruce Mirken analyzes this claim and similar theories that have also been widely promoted. JSJ] The AIDS denialists, who dispute not only the role of HIV in AIDS but nearly all scientific knowledge about the epidemic, regularly claim that the very notion of AIDS as a distinct medical condition is a mistake. What medicine has identified as a major epidemic, they insist, is nothing of the sort.
A number of variations on this theme have been put forth. Some have argued that AIDS is nothing but a "group fantasy" or "epidemic hysteria."(1) Others claim that several separate but real medical problems have been wrongly lumped together. ACT UP San Francisco has repeatedly claimed that "AIDS is over," suggesting that it did exist at one time but has somehow come to an end.
While most in the denialist camp accept some physical cause or causes for the illness we call AIDS, they claim science has fundamentally misunderstood what is going on, leading to faulty conclusions about causation.
"AIDS by definition is not new and is not a disease," the web site of HEAL Toronto declares. "AIDS is a new name for 29 old illnesses and conditions, including yeast infections, diarrhea, pneumonia, cancer and tuberculosis."(2)Christine Maggiore of the Los Angeles group Alive and Well adds that "every AIDS indicator disease occurs among people who test HIV negative," existed prior to AIDS, and has "medically proven causes that do not involve HIV."(3)
AIDS, in this view, is just a new name given these old diseases when they occur in people who test positive for HIV antibodies. Furthermore, it is claimed that inclusion of a positive HIV test in the criteria for an AIDS diagnosis has created a phony connection between these illnesses and HIV: "Pneumonia + positive HIV test = AIDS," Maggiore writes, but "Pneumonia + negative HIV test = pneumonia," thus creating "the illusion of a perfect correlation."(4)
Though factually wrong, such statements appear regularly in denialist literature.
Another complaint is that the number of AIDS cases has been artificially increased by repeated changes in the official AIDS definition. Adding more conditions to the definition, it is argued, pumps up the number of cases even though those new cases may not even be ill.(2,4)
What Was New in 1981?
The notion that AIDS is simply "a new name for old diseases" requires ignoring years of history and reams of published medical data.
The official start of the AIDS epidemic dates from mid- 1981, when the U.S. Centers for Disease Control and Prevention's MORBIDITY AND MORTALITY WEEKLY REPORT described cases of Kaposi's sarcoma (KS) and Pneumocystis carinii pneumonia (PCP) in young, previously healthy gay men.(5,6) Detailed reports of these and other cases, a few involving heterosexual drug injectors, were published in several medical journals later that year.
Prior to 1980 KS and PCP were extraordinarily rare in the U.S. Annual incidence of KS ranged from 2.1 to 6.1 cases for every 10 million people,(7) usually occurring in older men of European descent. The disease generally progressed slowly, with an average survival time of 8-13 years.(7,8)
PCP was nearly as rare, and the drug used to treat it, pentamidine isothionate, could only be obtained through the CDC's Parasitic Disease Drug Service, which kept detailed statistics. Strictly a disease of people with weakened immunity due to disease, cancer chemotherapy or immune- suppressive treatment for organ transplantation, PCP had "never been convincingly demonstrated to occur in an immunologically normal adult."(9)In one study 98 percent of patients had known immune defects, and the others were all seriously ill infants. Even though most were quite sick even before their PCP, the disease often responded well to treatment and relapses were rare.(10)
These new PCP and KS cases shattered the pattern. Most patients were young men, often in their 20s and 30s, with no identifiable reason for weakened immunity. Their KS was "fulminant, malignant"(8) and rapidly progressing. Some had both PCP and KS, and most had a cluster of other problems including persistent fever, weight loss, swollen lymph nodes, and other infections usually associated with weakened immunity, including cytomegalovirus and toxoplasmosis. This unremitting barrage set victims on a downward spiral that commonly ended in death within a year.(5,6,8,9,11,12,13,14)
This onslaught of infections in people with no known reason for being sick was so unusual that the usually reserved British journal THE LANCET called it "bizarre" twice in one brief commentary.(15)Patients also showed unexplained weakness in their immune responses, with a consistent pattern of defects in their cellular immunity.(5,6,8,9,11,12)
The physicians treating these patients had no doubt they were seeing a new clinical syndrome ("syndrome" is the medical term for a group of signs or symptoms that appear together and indicate a particular condition). And these doctors weren't babes in the woods. Several treated large numbers of gay men living a "fast lane" existence including multiple sex partners and recreational drugs, while others worked at urban hospitals treating many drug addicts, yet none of them had seen anything like this.(16)
The Evolving Definition of AIDS
As with any new syndrome, scientists' understanding of AIDS evolved gradually, with the most obvious and severe manifestations noticed first and rarer or subtler ones recognized later. A careful review of how the CDC has defined a case of AIDS contradicts the cartoon version presented by the denialists and shows that the definition has evolved cautiously--perhaps too cautiously at times.
(For simplicity this analysis will focus on the CDC's AIDS case definition. While not followed universally, health authorities in other industrialized countries often use the CDC's work as a starting point. The enormous subject of AIDS in Africa and other third world areas requires a separate article.)
The CDC first published an AIDS case definition in September, 1982. AIDS was simply defined as "a disease, at least moderately predictive of a defect in cell-mediated immunity, occurring in a person with no known cause for diminished resistance to that disease." 13 specific diseases were listed.(17)
HIV (then known as HTLV-III or LAV) was discovered in 1984, but the CDC waited a full year, until after a discussion at the Conference of State and Territorial Epidemiologists, before revising the AIDS definition. This new definition added a small number of conditions which would be considered AIDS-defining if they occurred in a person with a positive HIV test. But the original list of infections still triggered an AIDS diagnosis without an HIV test if they occurred in a person with depleted CD4 (T-helper) cells and no known reason for immune dysfunction.(18)
It was soon clear that patients commonly experienced a much broader array of illnesses than the indicator diseases listed by the CDC. In 1987 the agency noted, "It became apparent that some progressive, seriously disabling, even fatal conditions (e.g. encephalopathy, wasting syndrome) affecting a substantial number of HIV-infected patients were not subject to epidemiological surveillance, as they were not included in the AIDS case definition." So the agency made another cautious revision, with encephalopathy (dementia) and wasting syndrome being the most notable additions to the list of indicator conditions.(19)
But the CDC's AIDS definition was still capturing only a narrow piece of the picture, and not always the most severe piece. "There are very many people who are very ill who don't have AIDS by the CDC definition," said Los Angeles AIDS specialist Scott Hitt, M.D. (who went on to head President Clinton's AIDS Council) in 1990. "There are also people with one KS lesion (qualifying them for an AIDS diagnosis) who are doing very well."(20)
Part of the problem was that the only opportunistic infections that made it into the CDC's database were whatever conditions triggered a patient's initial diagnosis. CDC spokespeople acknowledged they simply didn't have the means to track the rest.(20)
Pressure mounted on the agency to adopt a definition that was more reflective of the real-world clinical experience of the most seriously ill patients, and after a lengthy period of discussion and debate, the current definition went into effect in January, 1993. For the first time it allowed an AIDS diagnosis based purely on an immune system measure: a CD4 cell count below 200 or a CD4 percentage below 14. Based on strong epidemiological evidence, three conditions were also added as AIDS indicator diseases in people with HIV: invasive cervical cancer, pulmonary tuberculosis and recurrent pneumonia (defined as two or more episodes within one year).(21)
One thing did not change: The core list of 12 opportunistic infections--PCP, toxoplasmosis, etc.--that dated from the mid-1980s would still trigger an AIDS diagnosis even without a positive HIV test.(21,22) In other words--and contrary to the denialists' claims--a positive HIV test has never been required to diagnose AIDS in people with these otherwise rare illnesses.
At this point it is useful to refer again to Maggiore's version of the AIDS definition, variations of which appear throughout denialist literature: "Pneumonia + positive HIV test = AIDS," but "pneumonia + negative HIV test = pneumonia." In fact, pneumocystis pneumonia triggers an AIDS diagnosis regardless of HIV status, and in HIV- positive persons, more conventional bacterial and viral pneumonias do not automatically trigger an AIDS diagnosis. To qualify as AIDS they must happen at least twice within a year, because only such multiple episodes are strongly associated with immune suppression.(21) Simply put, the "illusory correlation" so harped on by the denialists is an illusion of their own invention.
Another favorite denialist complaint is that some of the toxicities of certain AIDS drugs match items in the list of AIDS-defining conditions. As with the assertions discussed above, this claim is based on a skewed and often blatantly inaccurate reading of the case definition. In any case, the list of toxicities often cited as "AIDS by prescription"(23) consists entirely of conditions whose association with HIV was well established before AZT and other antiretrovirals came into widespread use.
Duesberg's Epidemiology and Other Mysteries
A related but distinct thesis has been advanced by University of California Berkeley Prof. Peter Duesberg: AIDS is in fact several separate epidemics lumped together. Proof, he and colleague David Rasnick suggest, lies in the fact that members of different risk groups get different diseases. KS, he notes, is seen mostly in gay men, while "weight loss and tuberculosis predominate in intravenous drug users, and pneumonia and candidiasis are almost the only two of the 30 AIDS-defining diseases that are diagnosed in hemophiliacs."(24)
These "distinct, subepidemic-specific diseases," Duesberg and Rasnick argue, rule out a common cause, infectious or otherwise. They further insist that AIDS indicator conditions can be divided into those that are immune deficiency-related, like PCP, and those that aren't, such as KS. A significant proportion of AIDS cases, they note, are diagnosed based on these "non immune deficiency diseases."(24)
Duesberg's reading of the literature is, to put it gently, selective. For one thing, despite his repeated assertions to the contrary, an association between KS and weakened immunity had been well established in the medical literature prior to AIDS.(7)
As for his claims about differing opportunistic infections in different risk groups, it is hardly a surprise that populations with widely varying behaviors, lifestyles and health risks would experience severe immune deficiency somewhat differently, and such differences have indeed been noted. But even a cursory glance at the medical literature quickly dynamites Duesberg's claim that these differences are so dramatic as to constitute separate epidemics. For example, five years before Duesberg and Rasnick's assertion that pneumonia and candidiasis are "almost the only two" AIDS-defining conditions seen in hemophiliacs, a European hemophiliac cohort found that of 37 diagnosed with AIDS, 6 had toxoplasmosis, 3 had wasting syndrome, 3 had dementia, 2 had MAC, 1 had CMV and 1 had lymphoma as their AIDS- diagnosing illness.(25)
The same Duesberg/Rasnick article touts both the "drug-AIDS hypothesis" and the "new name for old diseases" theory with an impressive list of references purportedly showing that AIDS-defining illnesses had been widely identified in drug users prior to and without AIDS. Duesberg's chart has at times been borrowed by other denialists.(24,26)
But again his "evidence" wilts under close examination. For example, one reference he cites repeatedly--as evidence that immune deficiency, candidiasis, lymphadenopathy and weight loss had been documented in heroin addicts pre-AIDS- -is 1973 article by Pillari and Narus from the AMERICAN JOURNAL OF NURSING. But the article, it turns out, isn't a study but simply an anecdotal description of patients seen in one treatment program. It gives neither numbers of cases nor occurrence rates for any of the conditions described.(27)
In fact, Pillari and Narus specifically mention just one of the four conditions Duesberg attributes to them, lymphadenopathy. Candidiasis is perhaps implied by nonspecific references to "fungal infections," while immune deficiency and weight loss are implied even more vaguely and indirectly. And although Duesberg's chart lists all four conditions as "AIDS defining," nothing in the article comes remotely close to describing an illness that would meet the criteria for an AIDS diagnosis.(27)
Finally, a different spin has been put out by ACT UP San Francisco. Some of their materials echo the general denialist notion that the whole epidemic is a scam, but their most-repeated phrase in recent years has been, "AIDS is over." Such statements often refer to declining numbers of AIDS cases and deaths.(28)
But extensive evidence links those declines to improved anti-HIV treatment (for more on this see AIDS TREATMENT NEWS' special issue, "Treatment and Survival," Sept. 8, 2000). And for the families of the 10,198 people who died of AIDS during 1999 according to the most recent CDC figures,(29) AIDS is certainly not over.
References
1. Schmidt, Casper G., "The group-fantasy origins of AIDS," in THE AIDS CULT, edited by John Lauritsen and Ian Young, Asklepios USA, 1997.
2. MacDonald, Robert, "Healthy skepticism about HIV," HEAL Toronto web site, http://www.harmsen.net/heal/healthy_skeptic.html
3. Maggiore, Christine, WHAT IF EVERYTHING YOU KNEW ABOUT AIDS WAS WRONG? American Foundation For AIDS Alternatives, p. 51.
4. Maggiore, p. 1.
5. Gottlieb, MS, and others, "Pneumocystis pneumonia--Los Angeles," MORBIDITY AND MORTALITY WEEKLY REPORT, 1981: 30: 250-52.
6. Friedman-Kien, A and others, "Kaposi's sarcoma and pneumocystis pneumonia among homosexual Men--New York City and California," MORBIDITY AND MORTALITY WEEKLY REPORT, 1981: 30: 305-08.
7. Safai, B. and Good, R., "Kaposi's sarcoma, a review and recent developments," CLINICAL BULLETIN, 1980: 10: 62-69.
8. Friedman-Kien, A., "Disseminated Kaposi's sarcoma syndrome in young homosexual men," JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 1981: 5(4) 468-71.
9. Masur, H. and others, "An outbreak of community-acquired pneumocystis carinii pneumonia," NEW ENGLAND JOURNAL OF MEDICINE, 1981: 305: 1431-8.
10. Walzer, Peter D. and others, "Pneumocystis carinii pneumonia in the United States," ANNALS OF INTERNAL MEDICINE, 1974: 80: 83-93.
11. Gottlieb, Michael and others, "Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men," NEW ENGLAND JOURNAL OF MEDICINE, 1981: 305: 1425-31.
12. Siegal, Frederick and others, "Severe acquired immunodeficiencies in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions," NEW ENGLAND JOURNAL OF MEDICINE, 1981: 305: 1439-44
13. Durack, David, "Opportunistic infections and Kaposi's sarcoma in homosexual men," NEW ENGLAND JOURNAL OF MEDICINE, 1981: 305: 1465-7.
14. Hymes, Kenneth and others, "Kaposi's sarcoma in homosexual men--a report of eight cases," THE LANCET, 1981; ii: 598-600.
15. "Immunocompromised homosexuals," THE LANCET, 1981, ii: 1325-6.
16. Shilts, Randy, AND THE BAND PLAYED ON, updated edition, Penguin Books, 1988, chapters 2-8.
17. "Current trends update on acquired immune deficiency syndrome (AIDS)--United States," MORBIDITY AND MORTALITY WEEKLY REPORT, 1982: 31: 508-08.
18. "Current trends revision of the case definition of Acquired Immunodeficiency Syndrome for National Reporting-- United States," MORBIDITY AND MORTALITY WEEKLY REPORT, 1985: 34: 373-5.
19. "Revision of the CDC Surveillance Case Definition for Acquired Immunodeficiency Syndrome," MORBIDITY AND MORTALITY WEEKLY REPORT, 1987: 36(supplement no. 1S).
20. Mirken, Bruce, "AIDS Name Game: Help or Misery Turns on Obsolete Definition," LOS ANGELES READER, May 25, 1990, p. 3-4.
21. "1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults," MORBIDITY AND MORTALITY WEEKLY REPORT, 1992: 41: RR-17.
22. Kitty Bina and Dr. Richard Selick, CDC, personal communication.
23. Maggiore, p. 30.
24. Duesberg, P. and Rasnick, D., "The AIDS dilemma: Drug diseases blamed on a passenger virus," GENETICA, 104:85- 132, 1998.
25. Aronstan, A. and others, "HIV infection in haemophilia- -a European cohort," ARCHIVES OF DISEASE IN CHILDHOOD, 1993: 68: 521-24.
26. Maggiore, p. 56.
27. Pillari, George, and Narus, June, "Physical effects of heroin addiction," American Journal of Nursing, 1973, 73: 2105-8.
28. ACT UP San Francisco press release, "ACT UP San Francisco launches survive AIDS campaign," March 27, 2000.
29. U.S. HIV and AIDS Cases Reported through December 1999, year-end edition, Vol. 11, no. 2. 001201 ATN35606
---------------------------------------------------------------------------- ----
Copyright © 2000 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org http://www.aidsnews.org
Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. comments@aegis.org.
PaulKing - 14 Dec 2004 02:49 GMT What a load of nonsense. Almost every line is a distortion or an outright lie.
Third rate smear propaganda.
David Canzi -- non-mailable address - 14 Dec 2004 15:37 GMT I ran your recent postings listing names of dissidents through a sort program. Here are some representative excerpts from the output:
* Annemarie Colbin (New York, NY) * Annemarie Colbin (New York, NY) * Arnold W. Giddens (Shingle Springs, CA) * Arnold W. Giddens (Shingle Springs, CA) * Arnold W. Giddens (Shingle Springs, CA) * Arnold W. Giddens (Shingle Springs, CA) * Asit K. Chakraborty, Ph.D. (Omaha, NE) * Asit K. Chakraborty, Ph.D. (Omaha, NE) * Barry A. Liebling, Ph.D. (New York, NY) * Barry A. Liebling, Ph.D. (New York, NY) * Barry R. Alexavich (Cell Biologist, Bristol, CT) * Barry R. Alexavich (Cell Biologist, Bristol, CT) * Bernard K. Forscher, Ph.D (Ret. Editor Proc. Nat. Acad. Sci., Santa Fe, * Bernard K. Forscher, Ph.D (Ret. Editor Proc. Nat. Acad. Sci., Santa Fe, * Beverly E. Griffin, Ph.D. (Dir. Dept. Virology, Royal Postgrad. Med. * Beverly E. Griffin, Ph.D. (Dir. Dept. Virology, Royal Postgrad. Med. * Bob Guccione, Jr. (Editor Spin Magazine, New York, NY) * Bob Guccione, Jr. (Editor Spin Magazine, New York, NY)
Alberti Mirco, Naturopathic Physician, Bologna, Italy Alberti Mirco, Naturopathic Physician, Bologna, Italy Alexavich Barry R. (Cell Biologist, Bristol, Connecticut) Alexavich Barry R. (Cell Biologist, Bristol, Connecticut) Almeida Ricardo, Visiting Professor, Ecological issues, Southern New Almeida Ricardo, Visiting Professor, Ecological issues, Southern New Almendro Manuel, PhD in Psychology, (Spain) Almendro Manuel, PhD in Psychology, (Spain) Also MPH, completing a PhD in Public Health at New York University Also MPH, completing a PhD in Public Health at New York University Ambiel Roger, Nurse teacher, Zurich, Switzerland Ambiel Roger, Nurse teacher, Zurich, Switzerland Amoroso Serafino, N.D., PhD, DAHom, New Jersey Center for the Healing Amoroso Serafino, N.D., PhD, DAHom, New Jersey Center for the Healing Anastasopoulos Emmanuel MD, PhD, Athens, Greece Anastasopoulos Emmanuel MD, PhD, Athens, Greece
Bhavana Sen MBBS,D.O, DNB (Ophthal) 1 Moderator 10/10/2004 3:16 AM Bhavana Sen MBBS,D.O, DNB (Ophthal) 1 Moderator 10/10/2004 3:16 AM Bhavana Sen MBBS,D.O, DNB (Ophthal) 1 Moderator 10/7/2004 11:17 PM Bhavana Sen MBBS,D.O, DNB (Ophthal) 1 Moderator 10/7/2004 11:17 PM Cantani Ivan - "We should fight... " 1 Moderator 10/8/2004 9:29 PM Cantani Ivan - "We should fight... " 1 Moderator 10/8/2004 9:29 PM D.l. Berg - Micro/Molecular biologist (B.S.) 1 Moderator 10/10/2004 D.l. Berg - Micro/Molecular biologist (B.S.) 1 Moderator 10/10/2004 D.l. Berg - Micro/Molecular biologist (B.S.) 1 Moderator 10/30/2004 D.l. Berg - Micro/Molecular biologist (B.S.) 1 Moderator 10/30/2004 D.l. Berg - Micro/Molecular biologist (B.S.) 1 Moderator 10/7/2004 D.l. Berg - Micro/Molecular biologist (B.S.) 1 Moderator 10/7/2004 Dr Frank Vincent Lekey 1 Moderator 10/10/2004 3:21 AM Dr Frank Vincent Lekey 1 Moderator 10/10/2004 3:21 AM Dr Frank Vincent Lekey 1 Moderator 10/7/2004 10:48 PM Dr Frank Vincent Lekey 1 Moderator 10/7/2004 10:48 PM Dr. David Marnaw 1 Moderator 10/30/2004 10:50 PM Dr. David Marnaw 1 Moderator 10/30/2004 10:50 PM Dr. David Marnaw 1 Moderator 10/30/2004 10:59 PM Dr. David Marnaw 1 Moderator 10/30/2004 10:59 PM Dr. Francis Serrano 1 Moderator 10/8/2004 9:06 PM Dr. Francis Serrano 1 Moderator 10/8/2004 9:06 PM Dr. Robert S. Harris 1 Moderator 10/7/2004 11:12 PM Dr. Robert S. Harris 1 Moderator 10/7/2004 11:12 PM
 Signature David Canzi
|
|
|